Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists

Background: Good quality anticoagulation among patients with operated valvular heart disease is needed to reduce ischaemic and thromboembolic complications. There is limited evidence regarding factors that affect anticoagulation control in patients implanted with mechanical or tissue prosthetic valv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zulkifly, Hanis H., Pastori, Daniele, Lane, Deirdre A., Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917463/
https://www.ncbi.nlm.nih.gov/pubmed/36769789
http://dx.doi.org/10.3390/jcm12031141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917463/
https://www.ncbi.nlm.nih.gov/pubmed/36769789
http://dx.doi.org/10.3390/jcm12031141

Ejemplares similares